TrueNorth »

Crispr Therapeutics shares owned by TrueNorth

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by TrueNorth from 13F filings

Historical chart of TrueNorth investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by TrueNorth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by TrueNorth

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.5M 25k 62.60
2023-09-30 $1.2M 26k 45.39
2023-06-30 $1.4M 26k 56.14
2023-03-31 $1.1M 25k 45.23
2022-12-31 $1.0M 26k 40.65
2022-09-30 $1.7M 27k 65.36
2022-06-30 $1.7M 28k 60.76
2022-03-31 $1.8M 28k 62.76
2021-12-31 $1.9M 25k 75.77
2021-09-30 $2.6M 24k 111.94
2021-06-30 $3.8M 23k 161.88
2021-03-31 $3.2M 26k 121.84
2020-12-31 $3.5M 23k 153.09
2020-09-30 $2.0M 24k 83.63
2020-06-30 $2.8M 38k 73.48
2020-03-31 $1.6M 38k 42.41